Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells

Blood

Volumn 96, Issue 13, 2000, Pages 4307-4312

  Mir, Samy S ^a   Richter, Bettina W M ^a   Duckett, Colin S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; DNA BINDING PROTEIN; HYBRID PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; GENETICS; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTIGENS, CD30; APOPTOSIS; CELL SURVIVAL; DNA-BINDING PROTEINS; HODGKIN DISEASE; HUMANS; I-KAPPA B PROTEINS; LYMPHOMA, LARGE-CELL; NEOPLASM PROTEINS; NF-KAPPA B; PROTEINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR CELLS, CULTURED;

EID: 0034672237     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4307.h8004307_4307_4312     Document Type: Article

References (20)

1. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411-452.
2. Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol. 1994;6:407-413.
3. Beyaert R, Fiers W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity: what we do understand and what we do not. FEBS Lett. 1994;340:9-16.
4. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 1995;85:3378-3404.
5. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 1998;17:3261-3270.
6. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11:255-260.
7. Wallach D, Varfolomeev EE, Malinin NL, Goltsev W, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-367.
8. Wajant H, Grell M, Scheurich P. TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev. 1999;10:15-26.
9. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 1993;74:845-853.
10. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice caused by a point mutation in Fas ligand. Cell. 1994;76:969-976.
11. Chinnaiyan AM, O'Rourke K, Yu G-L, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 1996;274:990-992.
12. Kitson J, Raven T, Jiang Y-P, et al. A death-domain containing receptor that mediates apoptosis. Nature. 1996;384:372-375.
13. Marsters SA, Sheridan JP, Donahue CJ, et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr Biol. 1996;6:1669-1676.
14. Pan G, O'Rourke K, Chinnaiyan AU, et al. The receptor for the cytotoxic ligand TRAIL Science. 1997;276:111-113.
15. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505-512.
16. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 1995;81:495-504.
17. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 1996;274:782-784.
18. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell. 1996;87:565-576.
19. Van Antwerp DJ, Martin SJ, Kafri T, Green D, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 1996;274:787-789.
20. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 1994;78:739-750.